vs
Side-by-side financial comparison of Broadway Financial Corp (BYFC) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $9.4M, roughly 1.9× Broadway Financial Corp). Broadway Financial Corp runs the higher net margin — 1934.0% vs -3.0%, a 1937.0% gap on every dollar of revenue. On growth, Broadway Financial Corp posted the faster year-over-year revenue change (10.1% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-13.0K). Over the past eight quarters, Broadway Financial Corp's revenue compounded faster (9.7% CAGR vs -10.1%).
Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
BYFC vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.4M | $18.3M |
| Net Profit | $1.0M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | — | -2.2% |
| Net Margin | 1934.0% | -3.0% |
| Revenue YoY | 10.1% | -25.6% |
| Net Profit YoY | -21.8% | 26.7% |
| EPS (diluted) | $0.02 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.4M | $18.3M | ||
| Q3 25 | $9.0M | $15.9M | ||
| Q2 25 | $8.1M | $16.1M | ||
| Q1 25 | $8.3M | $18.9M | ||
| Q4 24 | $8.6M | $24.7M | ||
| Q3 24 | $8.7M | $28.3M | ||
| Q2 24 | $8.2M | $25.8M | ||
| Q1 24 | $7.8M | $22.7M |
| Q4 25 | $1.0M | $-554.0K | ||
| Q3 25 | $-23.9M | $-1.8M | ||
| Q2 25 | $752.0K | $-1.5M | ||
| Q1 25 | $-2.7M | $-1.5M | ||
| Q4 24 | $1.3M | $-756.0K | ||
| Q3 24 | $516.0K | $1.7M | ||
| Q2 24 | $256.0K | $343.0K | ||
| Q1 24 | $-154.0K | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | -2.2% | ||
| Q3 25 | -256.2% | -9.9% | ||
| Q2 25 | 12.8% | -8.4% | ||
| Q1 25 | -45.3% | -7.2% | ||
| Q4 24 | 21.7% | -2.1% | ||
| Q3 24 | 8.5% | 6.8% | ||
| Q2 24 | 4.8% | 2.0% | ||
| Q1 24 | -2.9% | -5.8% |
| Q4 25 | 1934.0% | -3.0% | ||
| Q3 25 | -264.2% | -11.0% | ||
| Q2 25 | 9.3% | -9.3% | ||
| Q1 25 | -32.3% | -8.0% | ||
| Q4 24 | 15.3% | -3.1% | ||
| Q3 24 | 5.9% | 5.9% | ||
| Q2 24 | 3.1% | 1.3% | ||
| Q1 24 | -2.0% | -7.6% |
| Q4 25 | $0.02 | $-0.01 | ||
| Q3 25 | $-2.86 | $-0.05 | ||
| Q2 25 | $0.00 | $-0.05 | ||
| Q1 25 | $-0.39 | $-0.04 | ||
| Q4 24 | $0.07 | $-0.02 | ||
| Q3 24 | $-0.03 | $0.04 | ||
| Q2 24 | $0.02 | $0.01 | ||
| Q1 24 | $-0.02 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.5M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $262.8M | $37.0M |
| Total Assets | $1.3B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.5M | $10.7M | ||
| Q3 25 | $19.7M | $13.6M | ||
| Q2 25 | $29.5M | $12.5M | ||
| Q1 25 | $15.8M | $11.4M | ||
| Q4 24 | $61.4M | $15.7M | ||
| Q3 24 | $97.1M | $12.3M | ||
| Q2 24 | $89.8M | $11.9M | ||
| Q1 24 | $67.1M | $6.6M |
| Q4 25 | $262.8M | $37.0M | ||
| Q3 25 | $261.7M | $37.0M | ||
| Q2 25 | $284.7M | $30.4M | ||
| Q1 25 | $283.6M | $31.5M | ||
| Q4 24 | $285.0M | $32.6M | ||
| Q3 24 | $286.2M | $29.1M | ||
| Q2 24 | $282.1M | $23.5M | ||
| Q1 24 | $281.1M | $20.6M |
| Q4 25 | $1.3B | $57.1M | ||
| Q3 25 | $1.3B | $57.5M | ||
| Q2 25 | $1.2B | $52.6M | ||
| Q1 25 | $1.3B | $54.0M | ||
| Q4 24 | $1.3B | $59.2M | ||
| Q3 24 | $1.4B | $57.1M | ||
| Q2 24 | $1.4B | $53.0M | ||
| Q1 24 | $1.4B | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $230.0K | $2.3M |
| Free Cash FlowOCF − Capex | $-13.0K | $2.2M |
| FCF MarginFCF / Revenue | -0.1% | 12.0% |
| Capex IntensityCapex / Revenue | 2.6% | 0.5% |
| Cash ConversionOCF / Net Profit | 0.22× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.3M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $230.0K | $2.3M | ||
| Q3 25 | $3.8M | $-1.3M | ||
| Q2 25 | $3.0M | $1.8M | ||
| Q1 25 | $-4.3M | $-3.5M | ||
| Q4 24 | $1.4M | $865.0K | ||
| Q3 24 | $6.1M | $4.3M | ||
| Q2 24 | $9.8M | $1.4M | ||
| Q1 24 | $-11.7M | $-2.4M |
| Q4 25 | $-13.0K | $2.2M | ||
| Q3 25 | $3.7M | $-1.5M | ||
| Q2 25 | $3.0M | $1.7M | ||
| Q1 25 | $-4.4M | $-3.5M | ||
| Q4 24 | $1.3M | $470.0K | ||
| Q3 24 | $6.1M | $4.1M | ||
| Q2 24 | $9.7M | $1.2M | ||
| Q1 24 | $-11.7M | $-2.5M |
| Q4 25 | -0.1% | 12.0% | ||
| Q3 25 | 41.1% | -9.6% | ||
| Q2 25 | 37.0% | 10.5% | ||
| Q1 25 | -52.4% | -18.8% | ||
| Q4 24 | 14.7% | 1.9% | ||
| Q3 24 | 69.6% | 14.4% | ||
| Q2 24 | 118.9% | 4.5% | ||
| Q1 24 | -149.7% | -11.1% |
| Q4 25 | 2.6% | 0.5% | ||
| Q3 25 | 1.2% | 1.4% | ||
| Q2 25 | 0.2% | 1.0% | ||
| Q1 25 | 0.2% | 0.3% | ||
| Q4 24 | 1.6% | 1.6% | ||
| Q3 24 | 0.3% | 0.7% | ||
| Q2 24 | 0.5% | 1.1% | ||
| Q1 24 | 0.7% | 0.6% |
| Q4 25 | 0.22× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 11.85× | 2.57× | ||
| Q2 24 | 38.21× | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BYFC
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
